Addus HomeCare (NASDAQ:ADUS) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen lowered shares of Addus HomeCare (NASDAQ:ADUS) from a strong-buy rating to a buy rating in a research note issued to investors on Sunday.

ADUS has been the topic of a number of other research reports. Royal Bank Of Canada lifted their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a report on Friday, November 7th. TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Barclays raised their price objective on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a report on Tuesday, November 4th. Finally, BMO Capital Markets began coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $135.44.

Addus HomeCare Trading Up 1.3%

NASDAQ ADUS opened at $113.80 on Friday. The company has a market cap of $2.10 billion, a P/E ratio of 24.37, a P/E/G ratio of 1.37 and a beta of 0.91. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $124.43. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.66 and a quick ratio of 1.66. The company has a 50-day moving average of $109.72 and a 200-day moving average of $112.94.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total value of $2,180,000.00. Following the completion of the transaction, the executive vice president owned 44,144 shares in the company, valued at $4,811,696. This represents a 31.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In the last quarter, insiders sold 20,316 shares of company stock worth $2,215,998. Company insiders own 4.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Royal Bank of Canada grew its stake in Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after purchasing an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after buying an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after buying an additional 2,952 shares in the last quarter. Jane Street Group LLC increased its stake in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after buying an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC raised its holdings in Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after acquiring an additional 4,439 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.